October 2, 2010

09.00 – 11.15        IV Session   ‘’State of art’’  lectures
Chairpersons: U. Dahlstrom (SE), A. Erglis (LV)

09.00 – 09.45        Personalized medicine in management of heart failure
(U. Dahlstrom, SE)

09.45 – 10.30        The role of  levosimendan in the treatment of heart failure (Y. Hasin, IL)

10.30 – 11.15        Devices for heart failure: CRT responders and non-responders - future treatment strategy (M. Buerke, DE)

11.15 – 12.15        Goodbye coffee

11.00 – 13.00        Certificates will be provided